Essential Medicines List 9th Edition, 2018
The EML is Access to medicines and vaccines is one of the cornerstones of universal health coverage (UHC) and is critical to the achievement of the health-related Sustainable Development Goals (SDGs).
This 9th Edition of the Essential Medicines List, Ministry of Health, Cambodia (EML) builds upon the foundation of the 8th edition which was published in 2015. The EML is designed to be a vital tool to strengthen and standardize treatment of common conditions in Cambodia for both the public and private sectors. It is expected that the document be used as the basis for prescribing and dispensing in our health system whether public, private or non-governmental organizations operating under the umbrella of the Ministry of Health, Kingdom of Cambodia.
The EML also provides crucial recommendations on priorities for procurement, donations and distribution of medicines and consumables in Cambodia. The four tiers (i.e., MPA, CPA1, CPA2, CPA3) of the healthcare delivery system of the country should have these medicines available at all times.
Guideline on Drugs, Medical Equipment and Health Products for Health Center.
In order to promote the improvement of healthcare services to the people, Ministry of Health has currently prepared a health strategic plan for 2008-2015, in which strengthening the capacity of all health officials is also a priority. At the same time, a curriculum on drugs and medical equipment management for health centers has been prepared and trained for officials at the health center level with the aim of providing clear knowledge and skills in managing drug stores more effectively.
Guideline on Drugs Medical Equipment and Health Products for Operational Districts
Managements a vital task for all government institutions, including the Ministry of Health, provincial health departments, and operational district and health service nationwide. In particular, the drugs, medical equipment and health products management is an essential part of the Ministry of Health and development partners.
Since2003, Department of Drugs and Food,Ministry of Health, in collaboration with RACHA, has developed computer system operational drugs inventories database (ODDID Version 2003) for Drugs managements. This system has been used and developed continuously since 2005 (ODDID Version 2005 and 2005.1) and most recently in 2011 (ODDID Version 2011). In 2006, with funding from USAID and in collaboration with RACHA, Essential Drugs Bureau, Department of Drugs and-food, reviewed and revised the guidelines on the drugs, medical equipment and health products management which were first prepared in 2001, and trained all drug store officers of operational district.
Law on the Management of Medicines
The Management of Medicines, which was approved by the National Assembly on 9 October 1996, during the 6th session of the 1st legislature, is fully documented as follows.
For more detailed information, please download the complete document.
Law-on-Compulsory-License
The purpose of this law is to promote the right to access pharmaceutical products for public health through the issuance of licenses to manufacture, export, and import pharmaceutical products within the country in urgent or emergency situations, or for non-commercial public use, or other public health circumstances as determined by the Ministry of Health.
Law on The Amendment of Law on Management of Pharmaceutical
Guidelines on the Pharmacovigilance System for National Programs in Public Health Interventions
Guidelines on the Pharmacovigilance System for National Programs in Public Health Interventions aim to ensure the safety and quality of medicines. Their purpose is to guarantee medicine safety by providing reliable and timely information on safety issues, thereby promoting pharmacovigilance activities nationwide and encouraging participation in WHO programs to monitor medicine safety at the international level.
These pharmacovigilance guidelines for national programs in public health interventions were developed through consultations with international pharmacovigilance experts and national public health intervention programs, including the National Malaria Center, the National Tuberculosis and Hansen’s Disease Center, the National Center for HIV/AIDS, Dermatology and STDs, and the National Immunization Program.
